Peptide vendors under active FDA/DOJ enforcement, shut down, or flagged as exit scams — every entry linked to its primary or attributed source. Know before you order.
Community-corroborated exit scam (NOT a legal record): PeptideCritic 26-post thread reports seizures + vendor going dark with funds ($3k loss reported); GLP1Forum sourcing thread confirms still offline as of 2026-07-16 ("hoping they come back online"). 2+ independent sources.
Operator "Tracy" vanished Dec 2024 with unshipped cohort, no refunds; Aug 2025 comeback then third disruption Mar 2026. Chronic exit-scam pattern.
FDA warning letter MARCS-CMS 721600 (2026-03-31, CDER): website (reviewed Jan–Mar 2026) offered "GLP-1 SM" (semaglutide), "GLP-2 TRZ" (tirzepatide), "GLP-3 RT" (retatrutide, dosing 1–2mg/wk titrating to 12mg) and BAC Water — deemed unapproved new drugs under FD&C 505(a). Part of the spring-2026 GLP-1 enforcement wave. Leading indicator of death, NOT death: firm still trading (community review 2026-07-11 cites live QR CoA access). Enforcement flag only; outreach NOT suppressed.
FDA warning letter MARCS-CMS 719337 (Dec 12, 2025, CDER) for marketing SARMs (S4 Andarine, LGD-4033, MK-2866) on pinnaclepeptides.com as unapproved new drugs. Leading indicator of death, NOT death: firm given opportunity to correct; still trading as of letter. Enforcement flag only, outreach NOT suppressed.
FDA warning letter MARCS-CMS 695156 (Dec 10, 2024, CDER): "Semaglutide" and "Retatrutide" sold on primepeptides.com deemed unapproved new drugs; social media directed consumers to purchase. One of a four-vendor same-day wave (with Swiss Chems, Summit Research, Xcel Peptides). Enforcement flag — leading indicator, verify current trading status before ordering.
FDA warning letter MARCS-CMS 695607 (2024-12-10): unapproved new drugs (semaglutide, retatrutide, cagrilintide, tirzepatide, mazdutide) sold via summitpeptides.shop; RUO claim deemed pretextual given social-media human-use marketing. Part of same-day 4-vendor wave with Prime Peptides/SwissChems/Xcel Peptides. Leading indicator only -- vendor still trading, not suppressing outreach.
FDA warning letter MARCS-CMS 695663 (Dec 10, 2024, CDER): "Semaglutide" and "Retatrutide" offered on swisschems.is deemed unapproved new drugs; social media directed consumers to purchase. Part of the Dec 10, 2024 four-vendor wave. Enforcement flag — leading indicator.
Re-check 2026-07-13: STILL TRADING. Storefront live (wholesalepeptides.com -> wholesalepeptide.com), BPC-157 in stock $38.99, cart active. FDA WL 06/17/2026 (unapproved new drugs) unchanged, no close-out. Both cited SKUs (Prostamax 20mg, Gonadorelin 5mg) now return empty = apparent compliance removal. New: catalog behind login/age+RUO gate; site footer "Powered by Sterling Path LLC". No exit-scam indicators. NOT suppressed. Danger window to mid-Aug 2026.
DOJ (E.D. Ky.) criminal case: Tailor Made Compounding LLC pleaded guilty to distributing unapproved new drugs (SARMs and peptides incl. BPC-157, CJC-1295, Ipamorelin, LGD-4033, MK-677) Oct 2018–Apr 2020; forfeited $1,788,906.82. Owner Jeremy Delk also pleaded guilty. Defunct.
Dead after FDA warehouse raid Jun 2025: site offline overnight, no order fulfilment; aminoasylum.shop now 301-redirects to peptidecoupons.com parked Coming Soon page (checked 2026-07-12). Owner pleaded guilty Dec 10 2025.
Ceased operations: founders Kawa/Stechkober pleaded guilty Dec 10 2025 (DOJ N.D. Ind.); site now shows closure notice and paradigmpeptides.com returns an empty page on fetch 2026-07-12.
Voluntary shutdown Mar 6 2026; largest US grey-market vendor ($7.4M/mo Dec 2025 sales); no refund process, pending orders lost.
Ceased operations around 2020 (ThePeptideList vendor review).
Permanently closed following a federal criminal case: operator Tyler Hall convicted for manufacturing and selling unapproved drugs (SARMs/SERMs and others) as Rat's Army, LLC and introducing misbranded drugs into interstate commerce. FDA/DOJ enforcement. Any storefront using the name today is likely an impostor.
Voluntary permanent closure announced Jan 27, 2026; discontinued all research-product sales. Not raided or criminally charged — exited ahead of enforcement pressure. Committed to fulfilling outstanding orders or issuing refunds before closing.
Facts, not opinions. Each vendor is listed only with a documented reason and a source link. We surface regulatory records and closures — we don’t publish a rating we can’t defend.
Enforcement claims link to the primary record. Any vendor marked FDA / DOJ enforcement links directly to the government warning letter or case — tagged Primary source. Shutdowns and scams cite the strongest available record, tagged Industry record (e.g. regulatory graveyards / closure trackers). Third-party vendor-review sites are used only as a minor secondary reference, never as the basis for an enforcement label.
“Still trading” matters most. An FDA warning letter is a leading indicator — vendors often keep selling for weeks before closing or being forced offline. A vendor that is live and under enforcement is the highest-risk case for a buyer, so we flag it explicitly rather than waiting for the site to go dark.
Status reflects the last date each vendor was checked (shown per entry) and can change. This page refreshes from PepAssure’s live database each time it’s opened. Informational only — not legal, medical, or purchasing advice. Vendor names and domains are identifiers, not endorsements.